RBR-3ypfxv进行中（未招募）未知
Evaluation of Intragastric Balloon effectiveness associated to diet on treatment of diabetic patients with BMI<35 - BMI - Body Mass Index
Faculdade de Medicina da Univesidade de São Paulo0 个研究点开始时间: 2017年5月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 21Y 至 59Y（—）
入选标准
- •Volunteers males or females, age between 21 and 59 years; Overweight or obesity grade I (BMI between 27 and 34.9); Non-insulin dependent Diabetes Mellitus, glycated hemoglobin <10%, anti-GAD 65 <10 and peptide C> 1; Previous esophagogastroduodenoscopy with negative Helicobacter pylori research; Approval of psychological and nutritional profile; Clinical / drug and behavioral treatment directed to overweight patients, with no success; Signed informed consent form.
排除标准
- •Contraindications to treatment with intragastric, clinical or endoscopic balloon; Impossibility of strict follow-up.
研究者
相似试验
尚未招募
2 期
Efficacy of BioEnterics Intragastric Balloon System for the treatment of morbid obesityMorbid obesityJPRN-UMIN000005521Division of Gastroenterology and Hepatology, University of Tsukuba Hospital12
招募中
不适用
Safety study of endoscopic intragastric balloon placement for obese patients with endocrine and metabolic diseasesObese patients with any of the metabolic disorders (diabetes, hypertension, dyslipidemia are diagnosed according to the diagnostic criteria of the Japan Diabetes Society, The Japanese Society of Internal Medicine, Japanese Atherosclerotic Disease Prevention Guidelines)JPRN-UMIN000040991Kanazawa university10
终止
不适用
Endoscopic Intragastric Balloon Placement for Weight Loss in Liver Transplant Waitlist CandidatesObesityLiver CirrhosisNCT02556138Mayo Clinic8
招募中
1 期
Safety of endoscopic intragastric ballooObesity with metabolic diseaseObesity, Metabolic diseaseD009765JPRN-jRCTs042190108Yamashita Taro10
尚未招募
不适用
Effectiveness Gastric Balloon in Obese AdolescentsObesity, MorbidNCT04209842Stanford University20